1. Brock JM, Billeter A, Muller-Stich BP, Herth F. Obesity and the lung: what we know today. Respiration. 2020; 99(10):856–66.
Article
2. Sood A, Shore SA. Adiponectin, leptin, and resistin in asthma: basic mechanisms through population studies. J Allergy (Cairo). 2013; 2013:785835.
Article
3. Jung SY, Park DC, Kim SH, Yeo SG. Role of obesity in otorhinolaryngologic diseases. Curr Allergy Asthma Rep. 2019; Jun. 19(7):34.
Article
4. Hamilos DL. Chronic rhinosinusitis endotyping: sharpening the focus on inflammation. J Allergy Clin Immunol. 2016; May. 137(5):1457–9.
Article
5. Liu W, Zeng Q, Zhou L, Luo R, Dong H. Association of leptin with disease severity and inflammation indicators in Chinese obese children with allergic rhinitis. Pediatr Allergy Immunol. 2018; Mar. 29(2):186–93.
Article
6. Bhattacharyya N. Associations between obesity and inflammatory sinonasal disorders. Laryngoscope. 2013; Aug. 123(8):1840–4.
Article
7. Song SY, Woo HJ, Bae CH, Kim YW, Kim YD. Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. Laryngoscope. 2010; May. 120(5):1046–50.
Article
8. Woo HJ, Yoo WJ, Bae CH, Song SY, Kim YW, Park SY, et al. Leptin up-regulates MUC5B expression in human airway epithelial cells via mitogen-activated protein kinase pathway. Exp Lung Res. 2010; Jun. 36(5):262–9.
Article
9. Kwak S, Kim YD, Na HG, Bae CH, Song SY, Choi YS. Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. Biochem Biophys Res Commun. 2018; May. 499(3):655–61.
Article
10. Mathur N, Mehdi SF, Anipindi M, Aziz M, Khan SA, Kondakindi H, et al. Ghrelin as an anti-sepsis peptide: review. Front Immunol. 2021; Jan. 11:610363.
Article
11. Wang H, Yang T, Shen Y, Wan C, Li X, Li D, et al. Ghrelin inhibits interleukin-6 production induced by cigarette smoke extract in the bronchial epithelial cell via NF-κB pathway. Inflammation. 2016; FEB. 39(1):190–8.
Article
12. Huang C, Zheng H, He W, Lu G, Li X, Deng Y, et al. Ghrelin ameliorates the human alveolar epithelial A549 cell apoptosis induced by lipopolysaccharide. Biochem Biophys Res Commun. 2016; May. 474(1):83–90.
Article
13. Russo C, Patane M, Vicario N, Di Bella V, Cosentini I, Barresi V, et al. Olfactory ensheathing cells express both ghrelin and ghrelin receptor in vitro: a new hypothesis in favor of a neurotrophic effect. Neuropeptides. 2020; Feb. 79:101997.
Article
14. Sato T, Nakamura Y, Shiimura Y, Ohgusu H, Kangawa K, Kojima M. Structure, regulation and function of ghrelin. J Biochem. 2012; Feb. 151(2):119–28.
Article
15. Fu T, Wang L, Zeng Q, Zhang Y, Sheng B, Han L. Ghrelin ameliorates asthma by inhibiting endoplasmic reticulum stress. Am J Med Sci. 2017; Dec. 354(6):617–25.
Article
16. Zheng H, Liang W, He W, Huang C, Chen Q, Yi H, et al. Ghrelin attenuates sepsis-induced acute lung injury by inhibiting the NF-κB, iNOS, and Akt signaling in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2019; Sep. 317(3):L381–91.
Article
17. Wang W, Xu X, Zheng M, Wan L. Lipopolysaccharides induces MUC5AC overproduction in human nasal epithelium. Eur Arch Otorhinolaryngol. 2013; Feb. 270(2):541–7.
Article
18. Chen D, Bellussi LM, Passali D, Chen L. LPS may enhance expression and release of HMGB1 in human nasal epithelial cells in vitro. Acta Otorhinolaryngol Ital. 2013; Dec. 33(6):398–404.
19. Kim HK, Kook JH, Kang KR, Oh DJ, Kim TH, Lee SH. Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC. Laryngoscope. 2016; Nov. 126(11):E347–55.
Article
20. Tong J, Gu Q. Expression and clinical significance of mucin gene in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2020; Aug. 20(11):63.
Article
21. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010; Dec. 363(23):2233–47.
Article
22. Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, et al. Muc5b is required for airway defence. Nature. 2014; Jan. 505(7483):412–6.
Article
23. Vassiliou AG, Vitsas V, Kardara M, Keskinidou C, Michalopoulou P, Rovina N, et al. Study of inflammatory biomarkers in COPD and asthma exacerbations. Adv Respir Med. 2020; 88(6):558–66.
Article
24. Imoto Y, Ueki S, Kato Y, Yoshida K, Morikawa T, Kimura Y, et al. Elevated serum leptin levels in patients with eosinophilic chronic rhinosinusitis. Front Pharmacol. 2022; Jan. 12:793607.
Article
25. Guven M, Bulut Y, Aladag I, Yelken K, Erdogan H. Serum leptin levels in patients with nasal polyposis. J Laryngol Otol. 2008; Jun. 122(6):590–2.
Article
26. Manley GC, Parker LC, Zhang Y. Emerging regulatory roles of dualspecificity phosphatases in inflammatory airway disease. Int J Mol Sci. 2019; Feb. 20(3):678.
Article
27. Song SY, Na HG, Kwak SY, Choi YS, Bae CH, Kim YD. Changes in mucin production in human airway epithelial cells after exposure to electronic cigarette vapor with or without nicotine. Clin Exp Otorhinolaryngol. 2021; Aug. 14(3):303–11.
Article
28. Zheng H, Wu D, Wu X, Zhang X, Zhou Q, Luo Y, et al. Leptin promotes allergic airway inflammation through targeting the unfolded protein response pathway. Sci Rep. 2018; Jun. 8(1):8905.
Article
29. Wu CR, Yang QY, Chen QW, Li CQ, He WY, Zhao YP, et al. Ghrelin attenuate cerebral microvascular leakage by regulating inflammation and apoptosis potentially via a p38 MAPK-JNK dependent pathway. Biochem Biophys Res Commun. 2021; May. 552:37–43.
Article
30. Deng B, Fang F, Yang T, Yu Z, Zhang B, Xie X. Ghrelin inhibits AngIIinduced expression of TNF-α, IL-8, MCP-1 in human umbilical vein endothelial cells. Int J Clin Exp Med. 2015; Jan. 8(1):579–88.